Log In
Print
BCIQ
Print
Print this Print this
 

cobimetinib (GDC-0973, RG7421) (formerly XL518)

Also known as: MEK inhibitor

  Manage Alerts
Collapse Summary General Information
Company Exelixis Inc.
DescriptionMEK inhibitor
Molecular Target MAP kinase kinase 1 (MAP2K1) (MEK1) ; MAP kinase kinase 2 (MAP2K2) (MEK2)
Mechanism of ActionMEK inhibitor
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today